Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathlyn Stone

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Annals of Neurology|April 24, 2012
Genomic testing update: whole genome sequencing may be worth the moneyKathlyn Stone
Annals of Neurology|June 22, 2012
Experts urge caution over unregulated stem cell therapiesKathlyn Stone
Annals of Neurology|June 29, 2010
Comparative effectiveness research in neurology: healthcare reform will increase the focus on finding the most effective--and affordable--treatmentKathlyn Stone
Annals of Neurology|February 1, 2011
NerveCenter: applying the lessons of HeLa cells to today's researchKathlyn Stone
The Lancet. Neurology|September 15, 2009
When a patient chooses death: divided attitudesKathlyn Stone
Annals of Neurology|September 17, 2013
Should ethics standards for overseas trials get a makeover?: Transparency in overseas medical research has improved, but several issues concerning ethics of protections for trial participants remain unsolvedKathlyn Stone
Annals of Neurology|October 31, 2012
NerveCenter: October 2012Kathlyn Stone
Annals of Neurology|June 22, 2012
What’s next after Geron? A stem cell research updateKathlyn Stone
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of Neurology|April 24, 2012
Genomic testing update: whole genome sequencing may be worth the moneyKathlyn Stone
Annals of Neurology|June 22, 2012
Experts urge caution over unregulated stem cell therapiesKathlyn Stone
Annals of Neurology|June 29, 2010
Comparative effectiveness research in neurology: healthcare reform will increase the focus on finding the most effective--and affordable--treatmentKathlyn Stone
Annals of Neurology|February 1, 2011
NerveCenter: applying the lessons of HeLa cells to today's researchKathlyn Stone
The Lancet. Neurology|September 15, 2009
When a patient chooses death: divided attitudesKathlyn Stone
Annals of Neurology|September 17, 2013
Should ethics standards for overseas trials get a makeover?: Transparency in overseas medical research has improved, but several issues concerning ethics of protections for trial participants remain unsolvedKathlyn Stone
Annals of Neurology|October 31, 2012
NerveCenter: October 2012Kathlyn Stone
Annals of Neurology|June 22, 2012
What’s next after Geron? A stem cell research updateKathlyn Stone
Pageof 3